Outcome of the Rights Issue Committee Meeting held on November 03, 2026

‘BL’ Indrayani Biotech Inclusive Growth T » Date: 03.11.2026 BSH Limited ' Dept: of Corporate Services, Floor 25, P] Towers, R Dalal Street, - Mumbai-400001. §crip Code: 526445 Dear Sir/Madam, Subject: Outcome of Rights [ssue Committee Meeting under Regulation 30 of SEBI {Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”) This is in continuation to our earlier intimations regarding the Rights Issue of Rights Equity Shares of face vatue 10/~ each of Indrayani Biotech Limited (“Company”). Pursuant to Regulation 30 and other applicable provisions of the SEBI LODR Regulations, we hereby inform you that the Rights Issue Committee of the Company, at its meeting held today, i.e., November 03, 2026, has considered and approved the Basis of Allotment of 83,64,036 Rights Equity Shares (Partly Paid-up) of face value 10/ each, issued at T15/- per Rights Equity Share {including a premium of X5/- per Cquity Share), on which Application Money of %3.75/- per Rights Equity Share (comprising 32.50/- towards face value and X1.25/- towards premium) has been received. The Committee considered, reviewed, and took on record the Basis of Allotment was finalized in consultation with the Designated Stock Exchange, BSE Limited, vide their approval email dated 02+ November 2026. Accordingly, pursuant to the Allotment, the pald-up-equity share capital of the Company has increased from I 45,53,62,560 comprising of 4,55,36,256 fully paid-up equity shares of ¥ 10 each to % 53,03,95,890) comprising of 5,30,39,589 fully paid-up Equity Shares and 8,60,703 partly paid-up (Rs. 2.50 paid-up) Equity Shares. The Meeting Commenced on 4.30 pmn and concluded at 5.30 pm. Kindly take the above information on your recard. Thanking you, Yours Faithfully For and Behalf of Indrayani Biotech Limited Nangavaram Mahadevan Ranganathan DIN: 06377402 Chairman of the Committee